| Assessment of breast pathologies using nonlinear microscopy YK Tao, D Shen, Y Sheikine, OO Ahsen, HH Wang, DB Schmolze, ... Proceedings of the National Academy of Sciences 111 (43), 15304-15309, 2014 | 215 | 2014 |
| Connecting blood and intratumoral Treg cell activity in predicting future relapse in breast cancer L Wang, DL Simons, X Lu, TY Tu, S Solomon, R Wang, A Rosario, ... Nature immunology 20 (9), 1220-1230, 2019 | 146 | 2019 |
| Comprehensive profiling of poor-risk paired primary and recurrent triple-negative breast cancers reveals immune phenotype shifts KE Hutchinson, SE Yost, CW Chang, RM Johnson, AR Carr, PR McAdam, ... Clinical Cancer Research 26 (3), 657-668, 2020 | 86 | 2020 |
| Raman spectroscopy for rapid evaluation of surgical margins during breast cancer lumpectomy WC Zúñiga, V Jones, SM Anderson, A Echevarria, NL Miller, C Stashko, ... Scientific reports 9 (1), 14639, 2019 | 78 | 2019 |
| Advances in microscopy techniques DB Schmolze, C Standley, KE Fogarty, AH Fischer Archives of pathology & laboratory medicine 135 (2), 255-263, 2011 | 76 | 2011 |
| EMDomics: a robust and powerful method for the identification of genes differentially expressed between heterogeneous classes S Nabavi, D Schmolze, M Maitituoheti, S Malladi, AH Beck Bioinformatics 32 (4), 533-541, 2016 | 72 | 2016 |
| Characterization and analysis of the composition and dynamics of the mammalian riboproteome M Reschke, JG Clohessy, N Seitzer, DP Goldstein, SB Breitkopf, ... Cell reports 4 (6), 1276-1287, 2013 | 65 | 2013 |
| Artificial intelligence for detection of microsatellite instability in colorectal cancer—a multicentric analysis of a pre-screening tool for clinical application A Echle, NG Laleh, P Quirke, HI Grabsch, HS Muti, OL Saldanha, ... ESMO open 7 (2), 100400, 2022 | 64 | 2022 |
| A phase II clinical trial of pembrolizumab and enobosarm in patients with androgen receptorpositive metastatic triplenegative breast cancer Y Yuan, JS Lee, SE Yost, PH Frankel, C Ruel, CA Egelston, W Guo, ... The oncologist 26 (2), 99-e217, 2021 | 57 | 2021 |
| Phase I/II trial of palbociclib, pembrolizumab and letrozole in patients with hormone receptor-positive metastatic breast cancer Y Yuan, JS Lee, SE Yost, PH Frankel, C Ruel, CA Egelston, W Guo, ... European Journal of Cancer 154, 11-20, 2021 | 44 | 2021 |
| Direct comparison between confocal and multiphoton microscopy for rapid histopathological evaluation of unfixed human breast tissue T Yoshitake, MG Giacomelli, LC Cahill, DB Schmolze, H Vardeh, ... Journal of biomedical optics 21 (12), 126021-126021, 2016 | 43 | 2016 |
| Transformer-based biomarker prediction from colorectal cancer histology: A large-scale multicentric study SJ Wagner, D Reisenbüchler, NP West, JM Niehues, J Zhu, S Foersch, ... Cancer Cell 41 (9), 1650-1661. e4, 2023 | 41 | 2023 |
| Crowdsourcing scoring of immunohistochemistry images: Evaluating performance of the crowd and an automated computational method H Irshad, EY Oh, D Schmolze, LM Quintana, L Collins, RM Tamimi, ... Scientific reports 7 (1), 43286, 2017 | 38 | 2017 |
| Mutation and immune profiling of metaplastic breast cancer: correlation with survival M Afkhami, D Schmolze, SE Yost, PH Frankel, A Dagis, IU Amanam, ... PLoS One 14 (11), e0224726, 2019 | 35 | 2019 |
| Phase I clinical trial of the combination of eribulin and everolimus in patients with metastatic triple-negative breast cancer JS Lee, SE Yost, S Blanchard, D Schmolze, HH Yin, R Pillai, K Robinson, ... Breast Cancer Research 21, 1-13, 2019 | 34 | 2019 |
| Accuracy of gross intraoperative margin assessment for breast cancer: experience since the SSO-ASTRO margin consensus guidelines A Nunez, V Jones, K Schulz-Costello, D Schmolze Scientific Reports 10 (1), 17344, 2020 | 32 | 2020 |
| Phase II Trial of Neoadjuvant Carboplatin and NabPaclitaxel in Patients with TripleNegative Breast Cancer Y Yuan, JS Lee, SE Yost, SM Li, PH Frankel, C Ruel, D Schmolze, ... The Oncologist 26 (3), e382-e393, 2021 | 31 | 2021 |
| Towards integration of 64Cu-DOTA-trastuzumab PET-CT and MRI with mathematical modeling to predict response to neoadjuvant therapy in HER2 + breast cancer AM Jarrett, DA Hormuth, V Adhikarla, P Sahoo, D Abler, L Tumyan, ... Scientific Reports 10 (1), 20518, 2020 | 31 | 2020 |
| Multi-panel immunofluorescence analysis of tumor infiltrating lymphocytes in triple negative breast cancer: Evolution of tumor immune profiles and patient prognosis TF He, SE Yost, PH Frankel, A Dagis, Y Cao, R Wang, A Rosario, TY Tu, ... PLoS One 15 (3), e0229955, 2020 | 31 | 2020 |
| Identification of tissue-specific DNA methylation signatures for thyroid nodule diagnostics JH Yim, AH Choi, AX Li, H Qin, S Chang, SWT Tong, P Chu, BW Kim, ... Clinical Cancer Research 25 (2), 544-551, 2019 | 30 | 2019 |
